← FDA DRUG APPROVALS

FDA ANDA · ANDA040162

PROCHLORPERAZINE MALEATE

Sponsor: IVAX SUB TEVA PHARMS

APPLICATION
ANDA040162
TYPE
ANDA
ORIGINAL APPROVAL
1998-01-20
LATEST ACTION
2002-07-29
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Discontinued

Products

PROCHLORPERAZINE MALEATEDiscontinued
PROCHLORPERAZINE MALEATE EQ 5MG BASE · TABLET · ORAL
PROCHLORPERAZINE MALEATEDiscontinued
PROCHLORPERAZINE MALEATE EQ 10MG BASE · TABLET · ORAL

Approval history

2002-07-29Manufacturing (CMC) · Supplement 11AP
2001-09-12Manufacturing (CMC) · Supplement 9AP
2000-11-13Manufacturing (CMC) · Supplement 7AP
2000-11-13Manufacturing (CMC) · Supplement 8AP
2000-10-17Labeling · Supplement 6AP
2000-05-01Manufacturing (CMC) · Supplement 5AP
2000-05-01Manufacturing (CMC) · Supplement 4AP
2000-01-28Manufacturing (CMC) · Supplement 3AP
1999-11-23Manufacturing (CMC) · Supplement 2AP
1998-12-09Manufacturing (CMC) · Supplement 1AP
1998-01-20OriginalLabelAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →